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Plasmodium falciparum mitogen-activated protein (MAP) kinases, a family of enzymes central to signal transduction processes
including inflammatory responses, are a promising target for antimalarial drug development. Our study shows for the first time
that the P. falciparum specific MAP kinase 2 (PfMAP2) is colocalized in the nucleus of all of the asexual erythrocytic stages of P.
falciparum and is particularly elevated in its phosphorylated form. It was also discovered that PfMAP2 is expressed in its highest
quantity during the early trophozoite (ring form) stage and significantly reduced in the mature trophozoite and schizont stages.
Although the phosphorylated formof the kinase is alwaysmore prevalent, its ratio relative to the nonphosphorylated form remained
constant irrespective of the parasites’ developmental stage. We have also shown that the TSH motif specifically renders PfMAP2
genetically divergent from the other plasmodial MAP kinase activation sites using Neighbour Joining analysis. Furthermore, TSH
motif-specific designed antibody is crucial in determining the location of the expression of the PfMAP2 protein. However, by using
immunoelectronmicroscopy, PPfMAP2were detected ubiquitously in the parasitized erythrocytes. In summary, PfMAP2may play
a far more important role than previously thought and is a worthy candidate for research as an antimalarial.
1. Introduction
The spread of antimalarial resistance, in Plasmodium falci-
parum populations, is an important factor in our inability to
effectively control this deadly cause ofmalaria. Consequently,
there is an urgent need to identify novel targets for a new gen-
eration of antimalarials. MAP kinases have a potential role in
the regulation of cell cycle machinery of the malaria parasite
upstream of the signal transduction pathways involved in
the control of Plasmodium falciparum proliferation. The
Plasmodium parasite is unable to survive in the human red
blood cell without protein kinases [1]. Plasmodium kinases
first reported in 1997 [2, 3] are a promising target for
new antimalarials due to divergence in the properties and
phylogenetic differences between Plasmodium and the host
which leaves a space to exploit and inhibit specific enzymes
that are crucial to Plasmodium [4–6].
In P. falciparum, two types of MAP kinases are known:
PfMAP1 and PfMAP2 [7]. Initially, only PfMAP1 was thought
to be expressed in both sexual and asexual stages of the
malaria parasite. Further studies confirmed that PfMAP2 is
also expressed in both stages, sexual and asexual. Both MAP
kinases differ from a normal 3-cascade MAPK usually found
in eukaryotes (MAPKKK-MAPKK-MAPK). Reverse genetic
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analysis showed that PfMAP2 plays an important role in
P. falciparum survivability in the intraerythrocytic life cycle
[7]. PfMAP2 is also known to play a compensatory role to
PfMAP1 [7]. Although PfMAP1 does not play an essential role
in schizogony and Gametocytogenesis its knockout harbours
an increase in PfMAP2 protein suggesting PfMAP1 is neces-
sary for asexual cycle survivability [3, 7]. PfMAP2 possesses
an atypical activation site which is the TSH motif instead
of the TXY motif conserved in MAPKs in other eukaryotes
[3]. PfMAP2 is unique in that it cannot be confined to a
specific MAPK family. Although both enzymes were origi-
nally groupedwithin the extracellular signal-regulated kinase
1, ERK1/ERK2 family of MAP kinases, a comprehensive
phylogenetic analysis [4] of the entire complement of human
protein kinase sequences indicates that PfMAP1 is clearly
closer to the recently describedERK7/8 [8, 9].Theuniqueness
of PfMAP2 is further strengthened by the finding that no
members of theMAPKK family are found in the Plasmodium
genome [8, 9].
Thus, PfMAP2 is seen as a potential drug target for further
investigation in hemotherapeutics. However, very little is
known about this protein and the function of PfMAP2 is
poorly understood.This studywas carried out to comprehend
and enhance the understanding of PfMAP2 protein in order
to convey it as a potential drug target.
2. Material and Methods
(i) In Vitro Culture of P. falciparum. P. falciparum 3D7 strain
was cultured with some alterations [10, 11]. Percentage of P.
falciparum used ranged between 8% and 10% parasitemia at
5% hematocrit.
(ii) Synchronization of P. falciparum Culture. P. falciparum
culture was synchronized using 5% D-Sorbitol as described
by Radfar et al. [11]. Briefly, the culture was pooled and
centrifuged at 2000×g for 5 minutes at room temperature.
Supernatant was discarded and 5% D-Sorbitol was added
at a ratio of 1 : 1 (v/v) for 15 minutes followed by centrifu-
gation (2000×g, 5 minutes, at room temperature). Pellets
were washed with washingmedium (RPMI1640, gentamycin,
HEPES, and hypoxanthine) twice before being added into a
new culture flask containing complete medium and freshly
processed O+ type blood at 2% hematocrit.
(iii) Extraction of P. falciparumProtein. Synchronized cultures
of P. falciparum were collected in a 15mL tube. Subsequently,
proteins from the parasites were extracted. Parasites were
subsequently harvested by suspending the red blood cell
(RBC) for 10 minutes at room temperature in a saponin lysis
buffer. Sampleswere centrifuged at 1300×g for 10minutes and
RBC was continuously lysed with saponin twice. Parasites
were then washed with phosphate buffered saline (PBS) and
the pelleted parasites were subsequently frozen at −80∘C.
Lysis buffer containing 1% Triton-X, 50mM Tris HCl
pH 8, protease inhibitor cocktail (Sigma USA), and phos-
phatase inhibitor cocktail were added to the parasite pellet
at a concentration of 1 to 5 × 108 parasites per millilitre.
Samples were left on ice for 30 minutes and centrifuged
at 13,000×g for 10 minutes. A total of 20𝜇L supernatant
containing the parasites were aliquoted for protein analysis
using the Bradford assay [12]. The remaining supernatant
was mixed equally with 2x-sample buffer (0.5M Tris HCl pH
6.8, glycerol, 10% SDS, 0.05% 2-mercaptoethanol, and 0.5%
bromophenol blue) boiled for 5 minutes and centrifuged at
250×g, 5 minutes.
(iv) Western Blot. Samples were subjected to SDS-PAGE [13]
and blotted on a nitrocellulose membrane [14]. Immunoblot-
ting was carried out using a rabbit-anti-PfMAP2 anti-
body and a rabbit anti-phosphorylated PfMAP2 antibody
(PPfMAP2) at a dilution of 1 : 3000 overnight in +4∘C. Both
primary antibodies were prepared by Biogenes GmbH, Ger-
many. Briefly, two New Zealand White rabbits were immu-
nized with a synthetic peptide derived from PfMAP2 amino
acid sequence retrieved from PlasmoDB database raised
towards sequence CLKKQLTSHVVTR (residue 285–296).
Terminal cysteine residue was added on the N-terminus in
order to enable direct conjugation to the protein carrier. The
purification step allows the antibody to differentiate between
a phosphorylated and nonphosphorylated peptide. Rabbit-
anti-phosphorylated-PfMAP2 serum is the phosphorylated
form of the antibody which is the active form of the protein.
The activationmotif of PfMAP2 protein is reported to be TSH
which is different from the commonMAPKwhich is TXY [3].
Thepurified phosphorylated-specific antibody recognizes the
phosphorylation site (-pT – pS). Membranes were washed
using TBST solution three times followed by incubation
for an hour on an orbital shaker (50 rpm) with anti-rabbit
secondary antibody HRP-conjugated (1 : 15,000). Membranes
were washed, incubated with Enhanced Chemiluminescent
Western Blotting solution (ECL, Pierce) for 5 minutes prior
to film exposure. Densitometry analyses of PfMAP2 and
PPfMAP2 bands were performed using Bio-1D software
[15].
(v) Indirect Immunofluorescence Assay (IFA). The method
used is based on Ramasamy et al. [16] and Dorin et al. [3]
with some modifications. Blood smears of P. falciparum-
infected red blood cells were prepared on slides at different
stages of the parasite life cycle. Slides were then fixed with
a mixture of methanol and acetone (1 : 1 v/v) for one minute.
Control slides were prepared by incubating slides with 200U
of Lambda phosphatase (Calbiochem USA) for 30 minutes
at 4∘C. Next, 10% Fetal Bovine Serum (FBS) diluted in 1x
PBS was used to block the slides at 37∘C for 2 hours. Slides
were then washed with 1x PBS for 5 minutes, 3 times followed
by primary antibody incubation (PfMAP2 or phosphorylated
PfMAP2 antibody at 1 : 100 dilutions) for 1 hour at 37∘C.
Subsequently, slides were washed at intervals of 5 minutes for
3 times. Next, slides were incubated in secondary antibody
(conjugated FITC at 1 : 200 dilution) for 1 hour at 37∘C
and then were washed with PBS. Slides were then stained
with 4󸀠, 6-diamidino-2-phenylindole (DAPI) (2𝜇g/mL) for
30 minutes at 37∘C. After incubation, slides were washed
with 0.05% phosphate buffered saline-Tween (PBST) for 2
times and once with 1x PBS. Slides were mounted with
mounting medium and cover-slipped. Slides were observed
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using Olympus fluorescence microscope and images were
analyzed using Image Analyzer.
(vi) Statistical Analysis. The effect of parasite stage of devel-
opment and phosphorylation status on the relative intensities
(expression) of PfMAP2 were analyzed using a repeated
measures 2-way ANOVA, with a Bonferroni post test (Graph
Pad Prism).
(vii) Phylogenetic Analysis. Plasmodium and human MAP
kinase sequences were retrieved from PlasmoDB and Gen-
Bank, respectively. Similarity searches were done using the
Basic Local Alignment Search Tool (BLAST). A total of 30
amino acids which contain the activation motives from each
MAP kinases were used. The activation motif of Plasmodium
MAP1 is TDY [3], TSH forPlasmodiumMAP2 [3, 17], TEY for
ERK [18], TGY for p38 [19], and TPY for JNK [20]. MEGA 4
software was used to construct the Neighbour Joining (NJ)
phylogenetic tree with 1000 bootstrap replicates. NJ analyses
were performedwith distances calculated with the p-distance
parameter [21–23].
(viii) Bioinformatic Analysis of Localization of PfMAP2. All
computational studies were performed on a few bioinfor-
matics tools able to predict the subcellular localization of
PfMAP2 protein. PfMAP2 sequence was retrieved from
PlasmoDB (http://www.plasmodb.org/). Subcellular localiza-
tion of PfMAP2 protein was carried out using program
CELLO [24, 25], BaCelLo [26], Loctree [27], PProwler [28],
Euk-mPLoc 2.0 [29–32], and PredictProtein [33]. Nuclear
localization signals, PredictNLS [33], and NetNES 1.1 [34] in
PfMAP2 and analysis of PfMAP2 protein were done using
Signal Peptide [35] and Secretome v 2.0 [36].
(ix) Immunoelectron Microscopy (IEM) of Infected Ery-
throcyte. Immunoelectron microscopies were performed as
described by Bannister and Kent [37]. P. falciparum-infected
blood cultures were collected in a 15mL tube and subse-
quently centrifuged (2000×g, 15 minutes). The pellet was
suspended and fixed in McDowell Trump fixative prepared
in 0.1M phosphate buffer (pH 7.2) [37, 38]. Fixed specimens
were washed for a few times, dehydrated, and embedded in
London White Resin [39]. Ultrathin sections about 70 nm
in thickness were collected by using 200–300-mesh nickel
grids. The grids were incubated in blocking reagents for
30 minutes at room temperature and then incubated in
primary antibody (rabbit-anti-PPfMAP2 antibody) for two
hours at room temperature (dilutions of 1 : 10 were used).
After repeated washing in TBS-Tween 20 buffer for 5 times,
5 minutes each, the grids were incubated in goat anti-rabbit
IgG conjugated to 5 or 10 nm gold particles with dilution of
1 : 50. After washing step with the same buffer, the grids were
stained with uranyl acetate for 2 minutes and examined with
a transmission electron microscope H-9500.
3. Results and Discussion
Our studies showed that not only is PfMAP2 expressed in
all stages of asexual Plasmodium development (Figure 1), it
is also expressed specifically in the nucleus irrespective of
MAPK activation suggesting a more profound role being
played by PfMAP2 in contrast to PfMAP1.
We obtained a single band of 59 kDa in our Western blot
using the PfMAP2 and PPfMAP2 antibodies (Figure 1(a)).
Figure 1(b) showed that the intensity of PfMAP2 protein
is highest (2.3 × 105) at the ring stage compared to the
trophozoite (1.9×105) or schizont (1.6×105).The percentage
of activation, phosphorylated protein, is about 15.73% more
compared to the nonactive form of the protein during ring
stage. In the trophozoite stage, the percentage of activation is
slightly lower with total of 14.17%. During the schizont stage,
although the amount of PfMAP2 protein is lowest compared
to the rest, its phosphorylated intensity value is highest at
16.69% more than the nonphosphorylated PfMAP2. Our
studies also showed a greater degree of PfMAP2 expression
in the ring stage as opposed to the trophozoite and schizont
stages suggesting that PfMAP2 is required for Plasmodium
maturation since it is widely accepted that the ring stage
undergoes the most prolific cell differentiation compared to
the other asexual stages [4]. This is supported by microar-
ray results [4] which showed higher Pfmap2 mRNA in
ring stage as compared to later stages. A functional map2
gene is required for P. falciparum asexual growth [7]. The
results showed that expression of PfMAP2 protein is not
gametocyte-specific. The presence of both PfMAP2 and
phosphorylated PfMAP2 in all stages supports the idea that
PfMAP2 plays a crucial role [40] in the P. falciparum asexual
stage development of the asexual cycle especially during the
phase of parasite growth and maturation.
We have also provided evidence showing that the block-
ing peptide binds completely to the PfMAP2 and PPfMAP2
antibodies as shown by the lack of signal on theWestern blots
(data not shown).This confirms that both the phosphorylated
and nonphosphorylated form of antibodies generated using
the TSH motif is highly specific. Therefore, the signals
generated in theWestern blots and IFA are likely indicative of
the expression and localization of the PfMAP2 protein in the
parasite.This is the first report on the localization of PfMAP2
in the nucleus of the parasite as contrary to the previous
report of PfMAP2 being present in the cytoplasm of the
parasite [7]. We explain this as our antibody centres around
theTSHmotifwhereas the previously published expression of
PfMAP2 was based on the construction of a knock-in which
lacked the complete TSH motif [7]. Moreover, although
the expression of PfMAP2 in our study is concentrated in
the nucleus, there is a certain degree of expression in the
cytoplasm in the areas closest to the nucleus and this is
somewhat in agreement to what was observed in the previous
report [7] that there exists an overlap in expression in the
cytoplasm as well as the nucleus.
Figure 2(a) shows the Indirect Immunofluorescent Anal-
ysis (IFA) using PfMAP2 antibody without phosphatase and
Figure 2(b) shows PfMAP2 antibody with phosphatase treat-
ment. While Figure 2(c) shows the IFA result with PPfMAP2
antibody without phosphatase treatment Figure 2(d) shows
PPfMAP2 antibody with phosphatase treatment. All results
barring the control experiment shown in Figure 2(d) showed
that PfMAP2 and PPfMAP2 are localized in the parasite
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Figure 1: Expression levels of PfMAP2 at different stages of P. falciparum. (a) Expression pattern of PfMAP2 and phosphorylated PfMAP2
(PPfMAP2) within the developmental stages of P. falciparum. Stage-specific Western blot analyses were performed. H, host; R, ring stage;
T, trophozoite stage; S, schizont stage. 𝛽-actin was used as a standard to allow semiquantitative comparison between samples over time. (b)
Result shown is the average value of triplicate result (𝑛 = 3) +SE. A repeated measures 2-way ANOVA with Bonferroni post hoc analysis
showed that the overall RI of (PfMAP and PPfMAP2) significantly decreased as the parasite developed from ring to schizont (𝐹 = 43.8, DF =
2,12 𝑃 < 0.0001), and that the RI of PPfMAP2 was always significantly higher than PfMAP2. However the ratio of PfMAP2 and PPfMAP2
did not significantly differ between stages of development; that is, there was no interaction effect (𝐹 = 0.28, DF = 2,12 𝑃 = 0.759 (not shown
in the figure)). Immunoblotting was carried out using PfMAP2 peptide and PPfMAP2 peptide (1 : 3000).
nucleus in all intraerythrocytic stages (ring, trophozoite, and
schizont). We explain this in terms of the importance of
subcellular localization playing a vital role in physiological
functions, for example, in metabolic pathways, signal trans-
duction cascades, and structure associated functions [41].
For a protein to function properly, translocation to the right
compartments (intra/extracellular) occurs when the protein
assumes a soluble form or is attached to a membrane [41].
MAP kinases activated in the nucleus will activate the mito-
genic response and hence aid in parasite survivability. Several
other proteins are reported to be translocated into the nucleus
to play important roles in parasite survivability. Similar to
PfMAP2, Pf60 gene is locatedwithin the nucleus in all mature
blood stages [42] and its possible function is in regulating
homo- or heteromeric interactions in the parasite nucleus.
Apart from Pf60 gene, an unusual peroxiredoxin protein of P.
falciparum, PfnPrx (earlier known as MCP1) is also localized
to the nucleus of P. falciparum. PfnPrx is associated with the
parasite chromatin suggesting its potentially essential role
in the protection of nuclear DNA against oxidative stress
which is similar to Pf60 gene. Pfmrk is similar to mammalian
CDK7 and is activated by PfMAT1. It is interesting to
note that even though the nuclear localization signal (NLS)
sequence is absent in the amino acid sequence of the parasite
[43], both Pfmrk and PfMAT1 proteins are localized in the
nucleus. Pfmrk activates downstream substrates; PfRFC-5
and PfMCM6, hence suggesting that Pfmrk is important in
regulating DNA synthesis [43].
Table 1: PfMAP2 subcellular localization prediction through 6
available servers for eukaryotic proteins.
Bioinformatics tool Subcellular localization
CELLO Nucleus
BaCELLO Cytoplasm-nucleus-cytoplasm
LocTree Cytoplasm
PProwler Other than mitochondria peroxisome,secretory pathway
Euk-mPLoc 2.0 Cytoplasm, nucleus
PredictProtein Nuclear
The PfMAP2 sequence was analyzed using different
bioinformatics prediction software as described in the
methodology section and shown in Table 1. Four out of six
bioinformatics software programs predicted PfMAP2 would
be in the nucleus of the parasite. The NES sequence (nuclear
export signal) is found to be present in the PfMAP2 sequence;
hence the likelihood of it aiding nuclear import-export
mechanism in the parasite is high. Interestingly, NES is a
lysine residue which potentially interacts with the receptors
that export out protein from the cell’s nucleus [44] (Figure 3).
Upon further investigation, PfMAP2 does not contain a
nuclear localization signal (NLS). NLS is a signal or sequence
in a protein which transports protein into the cell nucleus
by nuclear transport. The function of NLS is known to be in
opposition to NES [42, 44, 45].
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Figure 2: Subcellular distribution of PfMAP2 in P. falciparum. Immunofluorescence analysis of (a) PfMAP2 without phosphatase treatment
localization in P. falciparum-infected red blood cells, (b) PfMAP2 with phosphatase treatment localization in P. falciparum-infected red blood
cells, (c) PPfMAP2 without phosphatase treatment localization in P. falciparum-infected red blood cells, and (d) PPfMAP2 with phosphatase
treatment localization in P. falciparum-infected red blood cells. P. falciparum-infected red blood cells were treated with DAPI (blue) and
incubated with primary antibody PfMAP2 (1 : 100) and secondary antibody conjugated-FITC (green) (1 : 200).
Furthermore, removal of the phosphorylation activity of
the parasite by the phosphatase treatment further supports
the specificity of the PPfMAP2 antibody which we designed
focussing on the TSH motif due to the complete lack of
signal as shown in Figure 2(d). MAPK is activated when
it is phosphorylated on both threonine and tyrosine [46].
However, in P. falciparum, PfMAP2 is shown to have atypical
property ofMAPK as its activationmotif is TSH as compared
to typical MAPK which is TXY [2, 3]. This divergence of
the plasmodial MAPK from the human protein kinase makes
them attractive as a potential and promising drug target
[5, 47, 48]. The human phosphorylated mitogen-activated
extracellular signal regulated protein kinase (MAPK/ERK-
P), phosphorylated protein kinase of 38 kDa (p38-P), and
phosphorylated stress-activated protein kinase (SAPK/JNK-
P) expression have been examined in Alzheimer’s disease
(AD), Pick's disease (PiD), progressive supranuclear palsy
(PSP), and corticobasal degeneration (CBD) [49]. Inhibition
of ERK activation reduced P. falciparum oocyst load and
infection prevalence inAnopheles stephensi as well as enhanc-
ing TGF-b1-mediated control of P. falciparum development
[50]. PfMAP2 is reported to be related to SNF-1 family [4].
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Figure 3: Schematic representation of the localization of phosphorylated PfMAP2. PPfMAP2 was shown to be in the nucleus. Expression of
PPfMAP2 also extends into the cytosol in the areas surrounding the nucleus (P-TSH). NES-tagged PfMAP2 are thought to be transported
from the cytosol to the nucleus. Upon phosphorylation, it will localize to the nucleus and activate downstream substrates.
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Figure 4: Phylogenetic analysis of PfMAP2 protein. Phylogenetic analysis using Neighbour joining (NJ) tree displaying the genetic
relationships among MAP kinases in Plasmodium species. Bootstrap support of more than 65% and distance is indicated. PlasmodiumMAP
kinases sequences were retrieved from PlasmoDB and Homo sapiens MAPK sequences representing ERK 7/8, JNK, and p38 were retrieved
from NCBI.
SNF-1 is a subfamily of protein kinase group which plays
a crucial role in regulating lipid metabolism and cell stress
response [51]. Activation of PfMAP2 protein in all the stages
supports the parasite metabolism by activating downstream
substrates which might be diverted compared to mammalian
MAP kinases.
We have also shown that the TSH motif of PfMAP2 sets
it apart from PfMAP1 as our Neighbour Joining analysis with
1000 bootstrap replicates suggests that it is less related to both
the human MAP kinases and the TXY motif of plasmodial
MAP1 as shown in Figure 4. This is in agreement with the
extensive divergence of the kinome of P. falciparum which
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Figure 5: Localization of PfMAP2 by immunoelectron microscopy. Ultrathin sections of P. falciparum parasites at intraerythrocyte stage
were labelled with rabbit anti-PPfMAP2 antibody followed with anti-rabbit secondary antibody conjugated with 15 nm colloidal gold particle.
Ultrathin sections of infected erythrocyte were observed under 7 000x (a), 25 000x (b), and 40 000x (c) magnification. Similarly PPfMAP2
staining in the schizont was observed under 8 000x magnification (d).
showed that PfMAP2 is located in a basal position relative
to other MAP kinases whereas PfMAP1 is clearly associated
with the human MAP kinase, ERK8 [4]. The divergence of
PfMAP2 from PfMAP1 as shown in Figure 4 using only the
activation sites of these proteins suggests that the TSH motif
is not only highly unique but it is also evolutionarily divergent
from the other MAP kinases inclusive of plasmodial MAP1
and human MAP kinases.
The data shown do not allow us to draw any conclusion
regarding detailed function of PfMAP2 during the intraery-
throcytic cycle. However, the additional information on
PfMAP2 protein could possibly aid in finding downstream
substrates and hence predict PfMAP2 pathway that is
involved in its protective mechanism similar to JNK/p38 and
also assist in parasite proliferation which is similar to ERK
function [52–54].
Immunogold labelling together with the use of transmis-
sion electron microscopy would aid in a more precise local-
ization of the activated protein.Therefore, to further confirm
the localization of PfMAP2, ultrathin sections of parasitized
red blood cell were probedwith anti-PPfMAP2 antibodies. At
lower magnification, PPfMAP2 staining was detected ubiq-
uitously. When the parasitized erythrocytes were observed
at higher magnification, the immunogold was detected in
various vesicular structures including nucleus (Figure 5).
Since we do not have a specific PPfMAP2 antibody which
is nucleus-specific, we have come to understand that the
expression of PfMAP2 is regionalised in various organelles of
the Plasmodium parasite. Here, we suggest that since PfMAP2
have a functional role during the pathological development
of the parasite [4], our data renders that further detailed
investigation should be done on this protein. Further studies
on the placement of PfMAP2 in the nuclear architecture will
aid in understanding on the gene regulation involved in its
function and the role of nuclear structure in MAP kinase
antigen variation.
4. Conclusion
The finding that the PfMAP2 protein is highly localized in
the parasite’s nucleus at all intraerythrocytic stages and its
expression is significantly dependent on the stage of P. falci-
parum asexual maturation further supports future potential
8 BioMed Research International
manipulation of PfMAP2 as a protein kinase inhibitor to halt
the spread of malaria.
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